* Sensus Healthcare Inc SRTS.OQ SRTS.O is expected to show a
rise in quarterly revenue when it reports results on November
4.
* The Boca Raton, Florida-based company is expected to report a
243.8% increase in revenue to $5.57 million from $1.62 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Sensus Healthcare Inc
is for a loss of 2 cents per share. For the same quarter last
year, the company reported a loss of 14 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Sensus
Healthcare Inc is $7, about 41.7% above its last closing price
of $4.08.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.05 -0.05 -0.02 Beat 63.6
Mar. 31 2021 -0.09 -0.10 -0.07 Beat 28.8
Dec. 31 2020 -0.10 -0.11 0.02 Beat 117.9
Sep. 30 2020 -0.14 -0.13 -0.14 Missed -3.7
Jun. -0.18 -0.18 -0.16 Beat 11.1
30 2020
Mar. 31 2020 -0.08 -0.07 -0.22 Missed -222
Dec. 31 2019 0.02 0.03 0.06 Beat 111.8
Sep. 30 2019 -0.04 -0.03 -0.04 Missed -20
This summary was machine generated November 3 at 13:33 GMT. All
figures in US dollars unless otherwise stated